U.S. market Closed. Opens in 1 day 6 hours 4 minutes

IMMX | Immix Biopharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/A-89.52MN/AN/AN/A
Cost of Revenue5.47K2.13K2.47K2.32K1.08K
Gross Profit-5.47K-89.52M-2.47K-2.32K-1.08K
Operating Expenses16.14M8.22M1.35M453.85K842.50K
Selling, General & Admin7.41M4.02M1.23M205.70K259.34K
Research & Development8.74M4.20M126.53K248.15K583.16K
Other Operating ExpensesN/AN/AN/A512.00224.00
Operating Income-16.14M-8.22M-1.35M-453.85K-842.50K
Other Expenses / Income572.01K-497.00-23.03M-676.46K-109.76K
Before Tax Income-15.57M-8.22M-24.38M-1.13M-952.26K
Income Tax Expenses26.41K10.27K6.01K17.55K20.55K
Net Income-15.43M-8.23M-24.38M-1.15M-972.81K
Interest ExpensesN/A497.00179.85K101.98K109.98K
Basic Shares Outstanding17.34M13.23M13.23M7.77M3.38M
Diluted Shares Outstanding17.34M13.23M13.23M7.77M3.38M
EBITDA-16.14M-8.22M-1.35M-451.53K-841.20K
EBITDA Margin0.00%9.18%0.00%0.00%0.00%
EBIT-15.40M-8.22M-24.20M-1.03M-842.27K
EBIT Margin0.00%9.18%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙